Key result
Higher early-life mean arterial pressure linked to ~43% higher CAD risk per 10 mm Hg.
Why the study?
It was unknown whether midlife blood pressure affects later life cardiovascular risk independent of later life blood pressure.
Does higher genetically predicted mean arterial pressure in midlife increase the risk of coronary artery disease in later life independently of later-life blood pressure?
Observational
Yes
Does higher genetically predicted mean arterial pressure in midlife increase the risk of coronary artery disease in later life independently of later-life blood pressure?
Elevated blood pressure in midlife independently increases the risk of later-life coronary artery disease, reinforcing the importance of optimizing blood pressure control throughout all stages of life.
Answers are grounded in this paper and cite their sources.
Midlife BP optimization may merit emphasis; extends MR evidence that early hypertension contributes to CAD independently of later levels.
Background Elevated blood pressure is a major cause of cardiovascular morbidity and mortality. However, it is not known whether midlife blood pressure affects later life cardiovascular risk independent of later life blood pressure. Methods and Results Using genetic association estimates from the UK Biobank and CARDIoGRAMplusC4D consortium, univariable mendelian randomization was performed to investigate the total effect of genetically predicted mean arterial pressure (MAP) at age ≤55 years on coronary artery disease (CAD) risk, and multivariable mendelian randomization was performed to investigate the effect of genetically predicted MAP on CAD risk after adjusting for genetically predicted MAP at age >55 years. In both univariable and multivariable mendelian randomization analyses, there was consistent evidence of higher genetically predicted MAP at age ≤55 years increasing CAD risk. This association persisted after adjusting for genetically predicted MAP at age >55 years, when considering nonoverlapping populations for the derivation of MAP and CAD risk genetic association estimates, when investigating only incident CAD events after age >55 years, and when restricting the analysis to variants with most heterogeneity in their associations with MAP ≤55 and >55 years. For a 10–mm Hg increase in genetically predicted MAP at age ≤55 years, the odds ratio of later life CAD was 1.43 (95% CI, 1.16–1.77; P =0.001) after adjusting for genetically predicted MAP at age >55 years. Conclusions These mendelian randomization findings support a cumulative lifetime effect of elevated blood pressure on increasing CAD risk. Clinical and public health efforts toward cardiovascular disease reduction should optimize blood pressure control throughout life.
No takes yet. Share an insight, caveat, or question.
Gill et al. (2020) conducted an observational in Coronary artery disease (CAD). Higher genetically predicted mean arterial pressure (MAP) at age ≤55 years vs. Lower genetically predicted MAP was evaluated on Later-life coronary artery disease (CAD) (OR 1.43, 95% CI 1.16-1.77, p=0.001). A 10-mm Hg increase in genetically predicted mean arterial pressure at age ≤55 years was associated with a 43% increased risk of later-life coronary artery disease, independent of blood pressure after age 55.
Synapse has enriched 10 related papers. Consider them for comparative context: